A phase II trial shows that pembrolizumab and bevacizumab yield a 54.1% intracranial response rate and a median overall ...

THE GLOBAL prevalence of Parkinson’s disease is projected to more than double by 2050, reaching 25.2 million cases, with ...

In conclusion, laparoscopic radical prostatectomy represents a promising alternative to traditional open surgery for early ...

Prostate cancer remains one of the most commonly diagnosed cancersworldwide, with 1.4 million new cases and over 375,000 ...

CANCER screening rates for breast and colorectal cancer rebounded in 2023, surpassing pre-pandemic levels, according to a ...

A SPECIFIC microbial ratio in the gut microbiome, characterised by a lower Bifidobacterium to Akkermansia ratio, has been ...

A recent study on T cell gene therapy trials shows that while secondary malignancies occur in a small percentage of patients, ...

Inadequate sleep duration and persistent late sleep onset are associated with significant fluctuations in blood glucose ...

The NICE has approved the first daily oral treatment for endometriosis symptoms for use within the NHS in England.

Discover a study that compared the effectiveness of P043 versus omalizumab in managing uncontrolled allergic asthma.

Explore the intricate relationship between therapeutic CPAP pressures and obstructive sleep apnea severity in children, ...

An acute necrotising myopathy is a distinct form of uncommon muscle disease characterised by the rapid advancement of ...